Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Glaukos Corporation stock logo
GKOS
Glaukos
$103.50
-0.1%
$95.84
$77.10
$163.71
$5.91B0.82739,359 shs289,937 shs
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$84.41
+0.7%
$83.18
$71.42
$109.58
$1.91B0.82169,905 shs75,102 shs
Penumbra, Inc. stock logo
PEN
Penumbra
$250.54
+0.3%
$269.14
$148.00
$310.00
$9.72B0.47453,066 shs233,847 shs
Teleflex Incorporated stock logo
TFX
Teleflex
$119.90
-1.4%
$123.14
$115.94
$249.91
$5.30B1.08630,875 shs360,058 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Glaukos Corporation stock logo
GKOS
Glaukos
-0.17%+2.25%+9.45%+23.77%-13.12%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
+0.67%+2.44%+1.87%+5.80%+3.83%
Penumbra, Inc. stock logo
PEN
Penumbra
+0.40%-1.24%-2.64%-4.51%+41.20%
Teleflex Incorporated stock logo
TFX
Teleflex
-1.23%+0.38%-1.28%-9.12%-43.36%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Glaukos Corporation stock logo
GKOS
Glaukos
4.4512 of 5 stars
4.41.00.04.42.71.70.6
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
2.7158 of 5 stars
2.21.03.30.02.62.51.3
Penumbra, Inc. stock logo
PEN
Penumbra
4.7196 of 5 stars
3.43.00.03.73.32.51.9
Teleflex Incorporated stock logo
TFX
Teleflex
4.6339 of 5 stars
3.04.02.53.91.91.71.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Glaukos Corporation stock logo
GKOS
Glaukos
2.75
Moderate Buy$134.6730.11% Upside
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
2.33
Hold$97.8315.90% Upside
Penumbra, Inc. stock logo
PEN
Penumbra
2.88
Moderate Buy$302.4020.70% Upside
Teleflex Incorporated stock logo
TFX
Teleflex
2.09
Hold$164.6337.30% Upside

Current Analyst Ratings Breakdown

Latest LMAT, PEN, TFX, and GKOS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/6/2025
Glaukos Corporation stock logo
GKOS
Glaukos
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$110.00 ➝ $72.00
5/5/2025
Teleflex Incorporated stock logo
TFX
Teleflex
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$140.00 ➝ $137.00
5/5/2025
Teleflex Incorporated stock logo
TFX
Teleflex
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$191.00 ➝ $173.00
5/2/2025
Glaukos Corporation stock logo
GKOS
Glaukos
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$140.00 ➝ $115.00
5/2/2025
Teleflex Incorporated stock logo
TFX
Teleflex
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Perform ➝ Sector Perform$150.00 ➝ $145.00
5/2/2025
Teleflex Incorporated stock logo
TFX
Teleflex
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$146.00 ➝ $137.00
5/1/2025
Glaukos Corporation stock logo
GKOS
Glaukos
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$140.00 ➝ $135.00
5/1/2025
Glaukos Corporation stock logo
GKOS
Glaukos
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$140.00 ➝ $115.00
5/1/2025
Glaukos Corporation stock logo
GKOS
Glaukos
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$176.00 ➝ $115.00
5/1/2025
Glaukos Corporation stock logo
GKOS
Glaukos
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Equal Weight$160.00 ➝ $86.00
4/24/2025
Penumbra, Inc. stock logo
PEN
Penumbra
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$320.00 ➝ $330.00
(Data available from 7/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Glaukos Corporation stock logo
GKOS
Glaukos
$383.48M15.42N/AN/A$13.91 per share7.44
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$219.86M8.67$2.39 per share35.33$15.00 per share5.63
Penumbra, Inc. stock logo
PEN
Penumbra
$1.19B8.12$2.88 per share86.97$29.99 per share8.35
Teleflex Incorporated stock logo
TFX
Teleflex
$3.05B1.74$25.35 per share4.73$92.11 per share1.30
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Glaukos Corporation stock logo
GKOS
Glaukos
-$146.37M-$2.37N/AN/AN/A-31.40%-10.66%-8.06%7/30/2025 (Estimated)
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$44.04M$1.9842.6338.902.2319.96%13.53%9.78%7/30/2025 (Estimated)
Penumbra, Inc. stock logo
PEN
Penumbra
$14.01M$1.06236.3650.012.243.41%11.14%8.40%7/29/2025 (Estimated)
Teleflex Incorporated stock logo
TFX
Teleflex
$69.68M$3.1737.827.901.884.96%14.73%8.79%7/30/2025 (Estimated)

Latest LMAT, PEN, TFX, and GKOS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2025Q2 2025
Glaukos Corporation stock logo
GKOS
Glaukos
-$0.26N/AN/AN/A$115.49 millionN/A
7/29/2025Q2 2025
Penumbra, Inc. stock logo
PEN
Penumbra
$0.81N/AN/AN/A$327.37 millionN/A
5/1/2025Q1 2025
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$0.50$0.48-$0.02$0.48$57.61 million$59.87 million
5/1/2025Q1 2025
Teleflex Incorporated stock logo
TFX
Teleflex
$2.88$2.91+$0.03$2.07$699.37 million$700.67 million
4/30/2025Q1 2025
Glaukos Corporation stock logo
GKOS
Glaukos
-$0.33-$0.22+$0.11-$0.32$102.78 million$106.66 million
4/23/2025Q1 2025
Penumbra, Inc. stock logo
PEN
Penumbra
$0.66$0.83+$0.17$1.00$315.72 million$324.14 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Glaukos Corporation stock logo
GKOS
Glaukos
N/AN/AN/AN/AN/A
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$0.800.95%N/A40.40%14 Years
Penumbra, Inc. stock logo
PEN
Penumbra
N/AN/AN/AN/AN/A
Teleflex Incorporated stock logo
TFX
Teleflex
$1.361.13%N/A42.90%N/A

Latest LMAT, PEN, TFX, and GKOS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/12/2025
Teleflex Incorporated stock logo
TFX
Teleflex
quarterly$0.341.09%5/20/20255/20/20256/16/2025
4/29/2025
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
quarterly$0.201%5/15/20255/15/20255/29/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Glaukos Corporation stock logo
GKOS
Glaukos
0.09
6.49
5.62
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
0.48
16.49
13.83
Penumbra, Inc. stock logo
PEN
Penumbra
0.02
6.30
3.68
Teleflex Incorporated stock logo
TFX
Teleflex
0.44
2.28
1.32

Institutional Ownership

CompanyInstitutional Ownership
Glaukos Corporation stock logo
GKOS
Glaukos
99.04%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
84.64%
Penumbra, Inc. stock logo
PEN
Penumbra
88.88%
Teleflex Incorporated stock logo
TFX
Teleflex
95.62%

Insider Ownership

CompanyInsider Ownership
Glaukos Corporation stock logo
GKOS
Glaukos
5.80%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
9.50%
Penumbra, Inc. stock logo
PEN
Penumbra
4.20%
Teleflex Incorporated stock logo
TFX
Teleflex
1.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Glaukos Corporation stock logo
GKOS
Glaukos
78057.14 million53.83 millionOptionable
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
49022.59 million20.45 millionOptionable
Penumbra, Inc. stock logo
PEN
Penumbra
4,50038.73 million37.10 millionOptionable
Teleflex Incorporated stock logo
TFX
Teleflex
14,10044.19 million43.57 millionOptionable

Recent News About These Companies

Teleflex closes deal with BIOTRONIK
Teleflex (NYSE:TFX) Stock Rating Lowered by Wall Street Zen
Zacks Research Has Bearish Forecast for Teleflex Q2 Earnings

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Glaukos stock logo

Glaukos NYSE:GKOS

$103.50 -0.13 (-0.13%)
Closing price 07/3/2025 03:30 PM Eastern
Extended Trading
$103.42 -0.08 (-0.07%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

LeMaitre Vascular stock logo

LeMaitre Vascular NASDAQ:LMAT

$84.41 +0.56 (+0.67%)
Closing price 07/3/2025 01:44 PM Eastern
Extended Trading
$84.41 0.00 (0.00%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

Penumbra stock logo

Penumbra NYSE:PEN

$250.54 +0.80 (+0.32%)
Closing price 07/3/2025 03:53 PM Eastern
Extended Trading
$250.54 0.00 (0.00%)
As of 07/3/2025 04:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Teleflex stock logo

Teleflex NYSE:TFX

$119.90 -1.69 (-1.39%)
Closing price 07/3/2025 03:30 PM Eastern
Extended Trading
$122.09 +2.19 (+1.83%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.